Tracleer® (bosentan)
Tracleer® (bosentan) is an oral dual endothelin receptor antagonist. Tracleer® is the only PAH therapy proven to delay disease progression, reduce severity and symptoms. Tracleer is the only oral PAH therapy with an established safety and tolerability profile in more than 60,000 patients worldwide.
US residents only: www.tracleer.com
Ventavis® (iloprost)
Ventavis® (inhaled iloprost) is an inhaled formulation of iloprost, a synthetic compound that is structurally similar to prostacyclin (PGI2) – a naturally occurring molecule that causes blood vessels to dilate, limits cellular hypertrophy, and inhibits platelet aggregation.
US residents only: www.4ventavis.com
Zavesca® (miglustat)
Miglustat, the active ingredient of Zavesca®, is an orally available molecule with a large volume of distribution, which was developed for the treatment of type 1 Gaucher disease (GD1).
US residents only: www.zavesca.com
